APO Research
Talk to an analyst

APO RESEARCH · REPORT

Amlodipine and Olmesartan

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Amlodipine and Olmesartan Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025192 pages

Choose your research edition.

Industry ResearchAmlodipine and Olmesartan Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Amlodipine and Olmesartan Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Amlodipine and Olmesartan Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Amlodipine and Olmesartan Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Amlodipine and Olmesartan Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Amlodipine and Olmesartan market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Amlodipine and Olmesartan is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Amlodipine and Olmesartan is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Amlodipine and Olmesartan is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Amlodipine and Olmesartan is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Amlodipine and Olmesartan include Teva, Glenmark Pharmaceuticals, Daiichi Sankyo, Torrent Pharmaceuticals, Steris Healthcare PVT Ltd, OLMIO, Matrix Laboratories, Macleods Pharmaceuticals and Jubilant Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Amlodipine and Olmesartan market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Amlodipine and Olmesartan and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Amlodipine and Olmesartan sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Amlodipine and Olmesartan market size, projected growth trends, production technologies, key applications, and end-use industries.

Amlodipine and Olmesartan Segment by Company

Teva

Glenmark Pharmaceuticals

Daiichi Sankyo

Torrent Pharmaceuticals

Steris Healthcare PVT Ltd

OLMIO

Matrix Laboratories

Macleods Pharmaceuticals

Jubilant Pharma

Aurobindo

Alembic Pharmaceuticals

Ajanta Pharma

Accord Healthcare

Amlodipine and Olmesartan Segment by Type

5/40 mg Tablets

5/20 mg Tablets

10/40 mg Tablets

10/20 mg Tablets

Amlodipine and Olmesartan Segment by Application

Hospital

Drug store

Amlodipine and Olmesartan Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Amlodipine and Olmesartan market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Amlodipine and Olmesartan and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Amlodipine and Olmesartan.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Amlodipine and Olmesartan market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Amlodipine and Olmesartan manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Amlodipine and Olmesartan in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Amlodipine and Olmesartan in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Amlodipine and Olmesartan Industry Trends Table 2. Amlodipine and Olmesartan Industry Drivers Table 3. Amlodipine and Olmesartan Industry Opportunities and Challenges Table 4. Amlodipine and Olmesartan Industry Restraints Table 5. Global Amlodipine and Olmesartan Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Amlodipine and Olmesartan Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Amlodipine and Olmesartan Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Amlodipine and Olmesartan Sales Market Share by Manufacturers Table 9. Global Amlodipine and Olmesartan Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Amlodipine and Olmesartan Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Amlodipine and Olmesartan Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Amlodipine and Olmesartan Manufacturers, Product Type & Application Table 13. Global Amlodipine and Olmesartan Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Amlodipine and Olmesartan by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 5/40 mg Tablets Table 17. Major Manufacturers of 5/20 mg Tablets Table 18. Major Manufacturers of 10/40 mg Tablets Table 19. Major Manufacturers of 10/20 mg Tablets Table 20. Global Amlodipine and Olmesartan Sales by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Amlodipine and Olmesartan Sales by Type (2021-2026) & (k units) Table 22. Global Amlodipine and Olmesartan Sales by Type (2027-2032) & (k units) Table 23. Global Amlodipine and Olmesartan Sales Market Share by Type (2021-2026) Table 24. Global Amlodipine and Olmesartan Sales Market Share by Type (2027-2032) Table 25. Global Amlodipine and Olmesartan Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 26. Global Amlodipine and Olmesartan Revenue by Type (2021-2026) & (k units) Table 27. Global Amlodipine and Olmesartan Revenue by Type (2027-2032) & (k units) Table 28. Global Amlodipine and Olmesartan Revenue Market Share by Type (2021-2026) Table 29. Global Amlodipine and Olmesartan Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Hospital Table 31. Major Manufacturers of Drug store Table 32. Global Amlodipine and Olmesartan Sales by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Amlodipine and Olmesartan Sales by Application (2021-2026) & (k units) Table 34. Global Amlodipine and Olmesartan Sales by Application (2027-2032) & (k units) Table 35. Global Amlodipine and Olmesartan Sales Market Share by Application (2021-2026) Table 36. Global Amlodipine and Olmesartan Sales Market Share by Application (2027-2032) Table 37. Global Amlodipine and Olmesartan Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 38. Global Amlodipine and Olmesartan Revenue by Application (2021-2026) & (k units) Table 39. Global Amlodipine and Olmesartan Revenue by Application (2027-2032) & (k units) Table 40. Global Amlodipine and Olmesartan Revenue Market Share by Application (2021-2026) Table 41. Global Amlodipine and Olmesartan Revenue Market Share by Application (2027-2032) Table 42. Global Amlodipine and Olmesartan Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Amlodipine and Olmesartan Sales by Region (2021-2026) & (k units) Table 44. Global Amlodipine and Olmesartan Sales Market Share by Region (2021-2026) Table 45. Global Amlodipine and Olmesartan Sales Forecasted by Region (2027-2032) & (k units) Table 46. Global Amlodipine and Olmesartan Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Amlodipine and Olmesartan Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 48. North America Amlodipine and Olmesartan Sales by Country (2021-2026) & (k units) Table 49. North America Amlodipine and Olmesartan Sales by Country (2027-2032) & (k units) Table 50. Europe Amlodipine and Olmesartan Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. Europe Amlodipine and Olmesartan Sales by Country (2021-2026) & (k units) Table 52. Europe Amlodipine and Olmesartan Sales by Country (2027-2032) & (k units) Table 53. Asia Pacific Amlodipine and Olmesartan Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Asia Pacific Amlodipine and Olmesartan Sales by Country (2021-2026) & (k units) Table 55. Asia Pacific Amlodipine and Olmesartan Sales by Country (2027-2032) & (k units) Table 56. South America, Middle East and Africa Amlodipine and Olmesartan Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. South America, Middle East and Africa Amlodipine and Olmesartan Sales by Country (2021-2026) & (k units) Table 58. South America, Middle East and Africa Amlodipine and Olmesartan Sales by Country (2027-2032) & (k units) Table 59. Global Amlodipine and Olmesartan Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Amlodipine and Olmesartan Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Amlodipine and Olmesartan Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Amlodipine and Olmesartan Revenue Market Share by Region (2021-2026) Table 63. Global Amlodipine and Olmesartan Revenue Market Share by Region (2027-2032) Table 64. Teva Company Information Table 65. Teva Business Overview Table 66. Teva Amlodipine and Olmesartan Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Teva Amlodipine and Olmesartan Product Portfolio Table 68. Teva Recent Development Table 69. Glenmark Pharmaceuticals Company Information Table 70. Glenmark Pharmaceuticals Business Overview Table 71. Glenmark Pharmaceuticals Amlodipine and Olmesartan Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Glenmark Pharmaceuticals Amlodipine and Olmesartan Product Portfolio Table 73. Glenmark Pharmaceuticals Recent Development Table 74. Daiichi Sankyo Company Information Table 75. Daiichi Sankyo Business Overview Table 76. Daiichi Sankyo Amlodipine and Olmesartan Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Daiichi Sankyo Amlodipine and Olmesartan Product Portfolio Table 78. Daiichi Sankyo Recent Development Table 79. Torrent Pharmaceuticals Company Information Table 80. Torrent Pharmaceuticals Business Overview Table 81. Torrent Pharmaceuticals Amlodipine and Olmesartan Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Torrent Pharmaceuticals Amlodipine and Olmesartan Product Portfolio Table 83. Torrent Pharmaceuticals Recent Development Table 84. Steris Healthcare PVT Ltd Company Information Table 85. Steris Healthcare PVT Ltd Business Overview Table 86. Steris Healthcare PVT Ltd Amlodipine and Olmesartan Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Steris Healthcare PVT Ltd Amlodipine and Olmesartan Product Portfolio Table 88. Steris Healthcare PVT Ltd Recent Development Table 89. OLMIO Company Information Table 90. OLMIO Business Overview Table 91. OLMIO Amlodipine and Olmesartan Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. OLMIO Amlodipine and Olmesartan Product Portfolio Table 93. OLMIO Recent Development Table 94. Matrix Laboratories Company Information Table 95. Matrix Laboratories Business Overview Table 96. Matrix Laboratories Amlodipine and Olmesartan Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Matrix Laboratories Amlodipine and Olmesartan Product Portfolio Table 98. Matrix Laboratories Recent Development Table 99. Macleods Pharmaceuticals Company Information Table 100. Macleods Pharmaceuticals Business Overview Table 101. Macleods Pharmaceuticals Amlodipine and Olmesartan Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Macleods Pharmaceuticals Amlodipine and Olmesartan Product Portfolio Table 103. Macleods Pharmaceuticals Recent Development Table 104. Jubilant Pharma Company Information Table 105. Jubilant Pharma Business Overview Table 106. Jubilant Pharma Amlodipine and Olmesartan Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Jubilant Pharma Amlodipine and Olmesartan Product Portfolio Table 108. Jubilant Pharma Recent Development Table 109. Aurobindo Company Information Table 110. Aurobindo Business Overview Table 111. Aurobindo Amlodipine and Olmesartan Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Aurobindo Amlodipine and Olmesartan Product Portfolio Table 113. Aurobindo Recent Development Table 114. Alembic Pharmaceuticals Company Information Table 115. Alembic Pharmaceuticals Business Overview Table 116. Alembic Pharmaceuticals Amlodipine and Olmesartan Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Alembic Pharmaceuticals Amlodipine and Olmesartan Product Portfolio Table 118. Alembic Pharmaceuticals Recent Development Table 119. Ajanta Pharma Company Information Table 120. Ajanta Pharma Business Overview Table 121. Ajanta Pharma Amlodipine and Olmesartan Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Ajanta Pharma Amlodipine and Olmesartan Product Portfolio Table 123. Ajanta Pharma Recent Development Table 124. Accord Healthcare Company Information Table 125. Accord Healthcare Business Overview Table 126. Accord Healthcare Amlodipine and Olmesartan Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Accord Healthcare Amlodipine and Olmesartan Product Portfolio Table 128. Accord Healthcare Recent Development Table 129. Key Raw Materials Table 130. Raw Materials Key Suppliers Table 131. Amlodipine and Olmesartan Distributors List Table 132. Amlodipine and Olmesartan Customers List Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. Amlodipine and Olmesartan Product Image Figure 2. Global Amlodipine and Olmesartan Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Amlodipine and Olmesartan Market Size (2021-2032) & (US$ Million) Figure 4. Global Amlodipine and Olmesartan Sales (2021-2032) & (k units) Figure 5. Global Amlodipine and Olmesartan Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Amlodipine and Olmesartan Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 5/40 mg Tablets Image Figure 9. 5/20 mg Tablets Image Figure 10. 10/40 mg Tablets Image Figure 11. 10/20 mg Tablets Image Figure 12. Global Amlodipine and Olmesartan Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Amlodipine and Olmesartan Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Amlodipine and Olmesartan Sales Market Share by Type (2021-2032) Figure 15. Global Amlodipine and Olmesartan Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Amlodipine and Olmesartan Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Amlodipine and Olmesartan Revenue Market Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Drug store Image Figure 20. Global Amlodipine and Olmesartan Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Amlodipine and Olmesartan Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Amlodipine and Olmesartan Sales Market Share by Application (2021-2032) Figure 23. Global Amlodipine and Olmesartan Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Amlodipine and Olmesartan Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Amlodipine and Olmesartan Revenue Market Share by Application (2021-2032) Figure 26. North America Amlodipine and Olmesartan Sales and Growth Rate (2021-2032) & (k units) Figure 27. North America Amlodipine and Olmesartan Sales Market Share by Country (2021-2032) Figure 28. U.S. Amlodipine and Olmesartan Sales and Growth Rate (2021-2032) & (k units) Figure 29. Canada Amlodipine and Olmesartan Sales and Growth Rate (2021-2032) & (k units) Figure 30. Mexico Amlodipine and Olmesartan Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Amlodipine and Olmesartan Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Amlodipine and Olmesartan Sales Market Share by Country (2021-2032) Figure 33. Germany Amlodipine and Olmesartan Sales and Growth Rate (2021-2032) & (k units) Figure 34. France Amlodipine and Olmesartan Sales and Growth Rate (2021-2032) & (k units) Figure 35. U.K. Amlodipine and Olmesartan Sales and Growth Rate (2021-2032) & (k units) Figure 36. Italy Amlodipine and Olmesartan Sales and Growth Rate (2021-2032) & (k units) Figure 37. Netherlands Amlodipine and Olmesartan Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Amlodipine and Olmesartan Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Amlodipine and Olmesartan Sales Market Share by Country (2021-2032) Figure 40. China Amlodipine and Olmesartan Sales and Growth Rate (2021-2032) & (k units) Figure 41. Japan Amlodipine and Olmesartan Sales and Growth Rate (2021-2032) & (k units) Figure 42. South Korea Amlodipine and Olmesartan Sales and Growth Rate (2021-2032) & (k units) Figure 43. Southeast Asia Amlodipine and Olmesartan Sales and Growth Rate (2021-2032) & (k units) Figure 44. India Amlodipine and Olmesartan Sales and Growth Rate (2021-2032) & (k units) Figure 45. Australia Amlodipine and Olmesartan Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Amlodipine and Olmesartan Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Amlodipine and Olmesartan Sales Market Share by Country (2021-2032) Figure 48. Brazil Amlodipine and Olmesartan Sales and Growth Rate (2021-2032) & (k units) Figure 49. South Africa Amlodipine and Olmesartan Sales and Growth Rate (2021-2032) & (k units) Figure 50. Saudi Arabia Amlodipine and Olmesartan Sales and Growth Rate (2021-2032) & (k units) Figure 51. Turkey Amlodipine and Olmesartan Sales and Growth Rate (2021-2032) & (k units) Figure 52. Argentina Amlodipine and Olmesartan Sales and Growth Rate (2021-2032) & (k units) Figure 53. UAE Amlodipine and Olmesartan Sales and Growth Rate (2021-2032) & (k units) Figure 54. Egypt Amlodipine and Olmesartan Sales and Growth Rate (2021-2032) & (k units) Figure 55. Chile Amlodipine and Olmesartan Sales and Growth Rate (2021-2032) & (k units) Figure 56. Global Amlodipine and Olmesartan Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Amlodipine and Olmesartan Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Amlodipine and Olmesartan Revenue (2021-2032) & (US$ Million) Figure 59. North America Amlodipine and Olmesartan Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Amlodipine and Olmesartan Revenue (2021-2032) & (US$ Million) Figure 61. Europe Amlodipine and Olmesartan Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Amlodipine and Olmesartan Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Amlodipine and Olmesartan Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Amlodipine and Olmesartan Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Amlodipine and Olmesartan Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Amlodipine and Olmesartan Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Amlodipine and Olmesartan Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 5/40 mg Tablets
  • 5/20 mg Tablets
  • 10/40 mg Tablets
  • 10/20 mg Tablets
Applications
  • Hospital
  • Drug store
Companies covered
  • Teva
  • Glenmark Pharmaceuticals
  • Daiichi Sankyo
  • Torrent Pharmaceuticals
  • Steris Healthcare PVT Ltd
  • OLMIO
  • Matrix Laboratories
  • Macleods Pharmaceuticals
  • Jubilant Pharma
  • Aurobindo
  • Alembic Pharmaceuticals
  • Ajanta Pharma
  • Accord Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Amlodipine and Olmesartan Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Amlodipine and Olmesartan Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Amlodipine and Olmesartan Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Amlodipine and Olmesartan Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Amlodipine and Olmesartan Market Dynamics
  1. 2.1 Amlodipine and Olmesartan Industry Trends
  2. 2.2 Amlodipine and Olmesartan Industry Drivers
  3. 2.3 Amlodipine and Olmesartan Industry Opportunities and Challenges
  4. 2.4 Amlodipine and Olmesartan Industry Restraints
3 Amlodipine and Olmesartan Market by Manufacturers
  1. 3.1 Global Amlodipine and Olmesartan Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Amlodipine and Olmesartan Sales by Manufacturers (2021-2026)
  3. 3.3 Global Amlodipine and Olmesartan Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Amlodipine and Olmesartan Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Amlodipine and Olmesartan Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Amlodipine and Olmesartan Manufacturers, Product Type & Application
  7. 3.7 Global Amlodipine and Olmesartan Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Amlodipine and Olmesartan Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Amlodipine and Olmesartan Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Amlodipine and Olmesartan Tier 1, Tier 2, and Tier 3
4 Amlodipine and Olmesartan Market by Type
  1. 4.1 Amlodipine and Olmesartan Type Introduction
  2. 4.1.1 5/40 mg Tablets
  3. 4.1.2 5/20 mg Tablets
  4. 4.1.3 10/40 mg Tablets
  5. 4.1.4 10/20 mg Tablets
  6. 4.2 Global Amlodipine and Olmesartan Sales by Type
  7. 4.2.1 Global Amlodipine and Olmesartan Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Amlodipine and Olmesartan Sales by Type (2021-2032)
  9. 4.2.3 Global Amlodipine and Olmesartan Sales Market Share by Type (2021-2032)
  10. 4.3 Global Amlodipine and Olmesartan Revenue by Type
  11. 4.3.1 Global Amlodipine and Olmesartan Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Amlodipine and Olmesartan Revenue by Type (2021-2032)
  13. 4.3.3 Global Amlodipine and Olmesartan Revenue Market Share by Type (2021-2032)
5 Amlodipine and Olmesartan Market by Application
  1. 5.1 Amlodipine and Olmesartan Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Drug store
  4. 5.2 Global Amlodipine and Olmesartan Sales by Application
  5. 5.2.1 Global Amlodipine and Olmesartan Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Amlodipine and Olmesartan Sales by Application (2021-2032)
  7. 5.2.3 Global Amlodipine and Olmesartan Sales Market Share by Application (2021-2032)
  8. 5.3 Global Amlodipine and Olmesartan Revenue by Application
  9. 5.3.1 Global Amlodipine and Olmesartan Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Amlodipine and Olmesartan Revenue by Application (2021-2032)
  11. 5.3.3 Global Amlodipine and Olmesartan Revenue Market Share by Application (2021-2032)
6 Global Amlodipine and Olmesartan Sales by Region
  1. 6.1 Global Amlodipine and Olmesartan Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Amlodipine and Olmesartan Sales by Region (2021-2032)
  3. 6.2.1 Global Amlodipine and Olmesartan Sales by Region (2021-2026)
  4. 6.2.2 Global Amlodipine and Olmesartan Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Amlodipine and Olmesartan Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Amlodipine and Olmesartan Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Amlodipine and Olmesartan Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Amlodipine and Olmesartan Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Amlodipine and Olmesartan Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Amlodipine and Olmesartan Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Amlodipine and Olmesartan Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Amlodipine and Olmesartan Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Amlodipine and Olmesartan Revenue by Region
  1. 7.1 Global Amlodipine and Olmesartan Revenue by Region
  2. 7.1.1 Global Amlodipine and Olmesartan Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Amlodipine and Olmesartan Revenue by Region (2021-2026)
  4. 7.1.3 Global Amlodipine and Olmesartan Revenue by Region (2027-2032)
  5. 7.1.4 Global Amlodipine and Olmesartan Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Amlodipine and Olmesartan Revenue (2021-2032)
  8. 7.2.2 North America Amlodipine and Olmesartan Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Amlodipine and Olmesartan Revenue (2021-2032)
  11. 7.3.2 Europe Amlodipine and Olmesartan Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Amlodipine and Olmesartan Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Amlodipine and Olmesartan Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Amlodipine and Olmesartan Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Amlodipine and Olmesartan Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Amlodipine and Olmesartan Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Amlodipine and Olmesartan Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 Glenmark Pharmaceuticals
  8. 8.2.1 Glenmark Pharmaceuticals Company Information
  9. 8.2.2 Glenmark Pharmaceuticals Business Overview
  10. 8.2.3 Glenmark Pharmaceuticals Amlodipine and Olmesartan Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Glenmark Pharmaceuticals Amlodipine and Olmesartan Product Portfolio
  12. 8.2.5 Glenmark Pharmaceuticals Recent Developments
  13. 8.3 Daiichi Sankyo
  14. 8.3.1 Daiichi Sankyo Company Information
  15. 8.3.2 Daiichi Sankyo Business Overview
  16. 8.3.3 Daiichi Sankyo Amlodipine and Olmesartan Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Daiichi Sankyo Amlodipine and Olmesartan Product Portfolio
  18. 8.3.5 Daiichi Sankyo Recent Developments
  19. 8.4 Torrent Pharmaceuticals
  20. 8.4.1 Torrent Pharmaceuticals Company Information
  21. 8.4.2 Torrent Pharmaceuticals Business Overview
  22. 8.4.3 Torrent Pharmaceuticals Amlodipine and Olmesartan Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Torrent Pharmaceuticals Amlodipine and Olmesartan Product Portfolio
  24. 8.4.5 Torrent Pharmaceuticals Recent Developments
  25. 8.5 Steris Healthcare PVT Ltd
  26. 8.5.1 Steris Healthcare PVT Ltd Company Information
  27. 8.5.2 Steris Healthcare PVT Ltd Business Overview
  28. 8.5.3 Steris Healthcare PVT Ltd Amlodipine and Olmesartan Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Steris Healthcare PVT Ltd Amlodipine and Olmesartan Product Portfolio
  30. 8.5.5 Steris Healthcare PVT Ltd Recent Developments
  31. 8.6 OLMIO
  32. 8.6.1 OLMIO Company Information
  33. 8.6.2 OLMIO Business Overview
  34. 8.6.3 OLMIO Amlodipine and Olmesartan Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 OLMIO Amlodipine and Olmesartan Product Portfolio
  36. 8.6.5 OLMIO Recent Developments
  37. 8.7 Matrix Laboratories
  38. 8.7.1 Matrix Laboratories Company Information
  39. 8.7.2 Matrix Laboratories Business Overview
  40. 8.7.3 Matrix Laboratories Amlodipine and Olmesartan Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Matrix Laboratories Amlodipine and Olmesartan Product Portfolio
  42. 8.7.5 Matrix Laboratories Recent Developments
  43. 8.8 Macleods Pharmaceuticals
  44. 8.8.1 Macleods Pharmaceuticals Company Information
  45. 8.8.2 Macleods Pharmaceuticals Business Overview
  46. 8.8.3 Macleods Pharmaceuticals Amlodipine and Olmesartan Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Macleods Pharmaceuticals Amlodipine and Olmesartan Product Portfolio
  48. 8.8.5 Macleods Pharmaceuticals Recent Developments
  49. 8.9 Jubilant Pharma
  50. 8.9.1 Jubilant Pharma Company Information
  51. 8.9.2 Jubilant Pharma Business Overview
  52. 8.9.3 Jubilant Pharma Amlodipine and Olmesartan Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Jubilant Pharma Amlodipine and Olmesartan Product Portfolio
  54. 8.9.5 Jubilant Pharma Recent Developments
  55. 8.10 Aurobindo
  56. 8.10.1 Aurobindo Company Information
  57. 8.10.2 Aurobindo Business Overview
  58. 8.10.3 Aurobindo Amlodipine and Olmesartan Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Aurobindo Amlodipine and Olmesartan Product Portfolio
  60. 8.10.5 Aurobindo Recent Developments
  61. 8.11 Alembic Pharmaceuticals
  62. 8.11.1 Alembic Pharmaceuticals Company Information
  63. 8.11.2 Alembic Pharmaceuticals Business Overview
  64. 8.11.3 Alembic Pharmaceuticals Amlodipine and Olmesartan Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Alembic Pharmaceuticals Amlodipine and Olmesartan Product Portfolio
  66. 8.11.5 Alembic Pharmaceuticals Recent Developments
  67. 8.12 Ajanta Pharma
  68. 8.12.1 Ajanta Pharma Company Information
  69. 8.12.2 Ajanta Pharma Business Overview
  70. 8.12.3 Ajanta Pharma Amlodipine and Olmesartan Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Ajanta Pharma Amlodipine and Olmesartan Product Portfolio
  72. 8.12.5 Ajanta Pharma Recent Developments
  73. 8.13 Accord Healthcare
  74. 8.13.1 Accord Healthcare Company Information
  75. 8.13.2 Accord Healthcare Business Overview
  76. 8.13.3 Accord Healthcare Amlodipine and Olmesartan Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Accord Healthcare Amlodipine and Olmesartan Product Portfolio
  78. 8.13.5 Accord Healthcare Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Amlodipine and Olmesartan Value Chain Analysis
  2. 9.1.1 Amlodipine and Olmesartan Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Amlodipine and Olmesartan Production Mode & Process
  6. 9.2 Amlodipine and Olmesartan Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Amlodipine and Olmesartan Distributors
  9. 9.2.3 Amlodipine and Olmesartan Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst